Latest Factsheet and Blog

Intl. Biotechnology Trust PLC
06 June 2024
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

 

IBT's factsheet for the month ended 30 April 2024 is now available directly via its web page. Please click here, then 'latest factsheet'.

 

IBT recently celebrated its 30-year anniversary, having launched as a pioneering investment trust dedicated to the nascent opportunity in biotech back in 1994. In the latest blog post, Marking IBT's 30-year anniversary with a look at the transformation of cancer therapy, Fund Managers Ailsa Craig and Marek Poszepczynski explore the key developments in cancer treatment during this time and the outlook for future breakthroughs, which are collectively profoundly changing the prospects for many patients.

 

The blog can be read here: https://www.schroders.com/en-gb/uk/individual/content/marking-ibt-s-30-year-anniversary-with-a-look-at-the-transformation-of-cancer-therapy/

 

To sign up for IBT updates by email, please click here.

 

 

ENDS

 

 

Enquiries:

 

Schroder Investment Management Limited

 

Augustine Chipungu (Press)

Kirsty Preston

 

Kerry Higgins (Company Secretary)                   

 

 

020 7658 6000

 

 

020 7658 6000

 


 

Kaso Legg Communications (Financial PR)

 

Charles Gorman                       

Henry Taylor

Effie Aye Maung Hider

 

 

 

 

IBT@kl-communications.com


 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings